Skip to content
Search

Latest Stories

Submit Guest Post

Omega-3s cut heart attack risk by 10 per cent

CONSUMING foods rich in omega-3 fatty acids, such as salmon, sardines and anchovies, can reduce the risk of a deadly heart attack by 10 per cent, a study out last Monday (27) said.

Researchers looked at blood and tissue omega-3 levels in participants of 19 studies across 16 countries, the report published in the US journal JAMA Internal Medicine said.


They found that while omega-3s “were associated with about a 10 per cent lower risk of fatal heart attacks,” the same reduction of risk did not hold true for non-fatal heart attacks.

That suggests “a more specific mechanism for benefits of omega-3s related to death,” the researchers concluded.

The results “provide the most comprehensive picture to-date of how omega-3s may influence heart disease,” co-author Liana Del Gobbo of the Stanford University School of Medicine added.

Both plant and seafood-based omega-3s were associated with lowering the risk of fatal heart attacks. Fish, the major source of omega-3s, are also rich in specific proteins, vitamin D, selenium and other minerals and elements, the researchers said.

Plant-based omega-3s are prevalent in walnuts, flaxseed oil, canola oil and some other seeds and nuts and their oils.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less